Lesion Heterogeneity and Long-Term Heteroresistance in Multidrug-Resistant Tuberculosis.
Where this comes from
- Record sourced from PubMed, PMID 34467983.
- Also identified by DOI 10.1093/infdis/jiab011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tuberculosis heteroresistance, in which only a fraction of the bacteria in a patient with tuberculosis contains drug-resistant mutations, has been a rising concern. However, its origins and prevalence remain elusive. Here, whole-genome sequencing was performed on 83 serial isolates from 31 patients with multidrug-resistant tuberculosis, and heteroresistance was detected in isolates from 21 patients (67.74%). Heteroresistance persisted in the host for long periods, spanning months to years, and was associated with having multiple tubercular lesions. Our findings indicate that heteroresistance is common and persistent in patients with multidrug-resistant tuberculosis and may affect the success of their treatment regimens.
Medical subject headings
- Antitubercular Agents
- Mycobacterium tuberculosis
- Sputum
- Tuberculosis, Multidrug-Resistant
- Whole Genome Sequencing